289 related articles for article (PubMed ID: 23674377)
1. Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
Mooiman KD; Maas-Bakker RF; Rosing H; Beijnen JH; Schellens JH; Meijerman I
Biomed Chromatogr; 2013 Sep; 27(9):1107-16. PubMed ID: 23674377
[TBL] [Abstract][Full Text] [Related]
2. The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel.
Mooiman KD; Maas-Bakker RF; Hendrikx JJ; Bank PC; Rosing H; Beijnen JH; Schellens JH; Meijerman I
J Pharm Pharmacol; 2014 Jun; 66(6):865-74. PubMed ID: 24392691
[TBL] [Abstract][Full Text] [Related]
3. Rapid and simultaneous measurement of midazolam, 1'-hydroxymidazolam and digoxin by liquid chromatography/tandem mass spectrometry: application to an in vivo study to simultaneously measure P-glycoprotein and cytochrome P450 3A activity.
Xue X; Huang M; Xiao H; Qin X; Huang L; Zhong G; Bi H
J Pharm Biomed Anal; 2011 Apr; 55(1):187-93. PubMed ID: 21316177
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a rapid and sensitive assay for simultaneous quantification of midazolam, 1'-hydroxymidazolam, and 4-hydroxymidazolam by liquid chromatography coupled to tandem mass-spectrometry.
Dostalek M; Macwan JS; Chitnis SD; Ionita IA; Akhlaghi F
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1629-33. PubMed ID: 20434409
[TBL] [Abstract][Full Text] [Related]
5. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
[TBL] [Abstract][Full Text] [Related]
6. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
[TBL] [Abstract][Full Text] [Related]
7. An automated, high-throughput, 384 well Cytochrome P450 cocktail IC50 assay using a rapid resolution LC-MS/MS end-point.
Youdim KA; Lyons R; Payne L; Jones BC; Saunders K
J Pharm Biomed Anal; 2008 Sep; 48(1):92-9. PubMed ID: 18584988
[TBL] [Abstract][Full Text] [Related]
8. A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry.
Qin CZ; Ren X; Tan ZR; Chen Y; Yin JY; Yu J; Qu J; Zhou HH; Liu ZQ
Biomed Chromatogr; 2014 Feb; 28(2):197-203. PubMed ID: 23946123
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions.
Zhang W; Han F; Guo P; Zhao H; Lin ZJ; Huang MQ; Bertelsen K; Weng N
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1169-77. PubMed ID: 20378422
[TBL] [Abstract][Full Text] [Related]
10. Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.
Gorski JC; Hall SD; Jones DR; VandenBranden M; Wrighton SA
Biochem Pharmacol; 1994 Apr; 47(9):1643-53. PubMed ID: 8185679
[TBL] [Abstract][Full Text] [Related]
11. UPLC-MS/MS analysis of the Michaelis-Menten kinetics of CYP3A-mediated midazolam 1'- and 4-hydroxylation in rat brain microsomes.
Venkatapura Chandrashekar D; DuBois B; Mehvar R
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1180():122892. PubMed ID: 34388602
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
Zhang S; Song N; Li Q; Fan H; Liu C
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):78-89. PubMed ID: 18614408
[TBL] [Abstract][Full Text] [Related]
13. Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1'-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry.
Burhenne J; Halama B; Maurer M; Riedel KD; Hohmann N; Mikus G; Haefeli WE
Anal Bioanal Chem; 2012 Mar; 402(7):2439-50. PubMed ID: 22252655
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of midazolam and 1'-hydroxymidazolam in human plasma by liquid chromatography with tandem mass spectrometry.
Li W; Luo S; Smith HT; Tse FL
Biomed Chromatogr; 2007 Aug; 21(8):841-51. PubMed ID: 17441219
[TBL] [Abstract][Full Text] [Related]
15. High-throughput assay to simultaneously evaluate activation of CYP3A and the direct and time-dependent inhibition of CYP3A, CYP2C9, and CYP2D6 using liquid chromatography-tandem mass spectrometry.
Yumoto Y; Endo T; Harada H; Kobayashi K; Nakabayashi T; Abe Y
Xenobiotica; 2024 Feb; 54(2):45-56. PubMed ID: 38265764
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a method using supported liquid extraction for the simultaneous determination of midazolam and 1'-hydroxy-midazolam in human plasma by liquid chromatography with tandem mass spectrometry detection.
Svanström C; Hansson GP; Svensson LD; Sennbro CJ
J Pharm Biomed Anal; 2012 Jan; 58():71-7. PubMed ID: 21993197
[TBL] [Abstract][Full Text] [Related]
17. Rapid and simultaneous determination of nifedipine and dehydronifedipine in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical herb-drug interaction study.
Wang XD; Li JL; Lu Y; Chen X; Huang M; Chowbay B; Zhou SF
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):534-44. PubMed ID: 17339138
[TBL] [Abstract][Full Text] [Related]
18. Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis.
Yao M; Zhu M; Sinz MW; Zhang H; Humphreys WG; Rodrigues AD; Dai R
J Pharm Biomed Anal; 2007 May; 44(1):211-23. PubMed ID: 17418993
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a fast and sensitive UPLC-MS/MS method for the quantification of six probe metabolites for the in vitro determination of cytochrome P450 activity.
De Bock L; Boussery K; Colin P; De Smet J; T'jollyn H; Van Bocxlaer J
Talanta; 2012 Jan; 89():209-16. PubMed ID: 22284482
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytochrome P450 inhibition assays using human liver microsomes by a cassette analysis /LC-MS/MS.
Zambon S; Fontana S; Kajbaf M
Drug Metab Lett; 2010 Aug; 4(3):120-8. PubMed ID: 20642444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]